These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 24625981
1. Two combined photosensitizers: a goal for more effective photodynamic therapy of cancer. Acedo P, Stockert JC, Cañete M, Villanueva A. Cell Death Dis; 2014 Mar 13; 5(3):e1122. PubMed ID: 24625981 [Abstract] [Full Text] [Related]
2. Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy. Broekgaarden M, de Kroon AI, Gulik TM, Heger M. Curr Med Chem; 2014 Mar 13; 21(3):377-91. PubMed ID: 23931271 [Abstract] [Full Text] [Related]
3. Regulated necrosis in HeLa cells induced by ZnPc photodynamic treatment: a new nuclear morphology. Soriano J, Villanueva A, Stockert JC, Cañete M. Int J Mol Sci; 2014 Dec 09; 15(12):22772-85. PubMed ID: 25501332 [Abstract] [Full Text] [Related]
4. Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy. Kim J, Santos OA, Park JH. J Control Release; 2014 Oct 10; 191():98-104. PubMed ID: 24892975 [Abstract] [Full Text] [Related]
5. Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity. Xu P, Chen J, Chen Z, Zhou S, Hu P, Chen X, Huang M. PLoS One; 2012 Oct 10; 7(5):e37051. PubMed ID: 22693566 [Abstract] [Full Text] [Related]
6. Photodynamic therapy using zinc phthalocyanine with low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells. Doustvandi MA, Mohammadnejad F, Mansoori B, Tajalli H, Mohammadi A, Mokhtarzadeh A, Baghbani E, Khaze V, Hajiasgharzadeh K, Moghaddam MM, Hamblin MR, Baradaran B. Photodiagnosis Photodyn Ther; 2019 Dec 10; 28():88-97. PubMed ID: 31454716 [Abstract] [Full Text] [Related]
7. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy. Dias LM, Sharifi F, de Keijzer MJ, Mesquita B, Desclos E, Kochan JA, de Klerk DJ, Ernst D, de Haan LR, Franchi LP, van Wijk AC, Scutigliani EM, Cavaco JEB, Tedesco AC, Huang X, Pan W, Ding B, Krawczyk PM, Heger M, Photodynamic Therapy Study Group. J Photochem Photobiol B; 2021 Mar 10; 216():112146. PubMed ID: 33601256 [Abstract] [Full Text] [Related]
8. Multiple Functions Integrated inside a Single Molecule for Amplification of Photodynamic Therapy Activity. Shi X, Zhan Q, Li Y, Zhou L, Wei S. Mol Pharm; 2020 Jan 06; 17(1):190-201. PubMed ID: 31804837 [Abstract] [Full Text] [Related]
9. Efficient induction of apoptosis in HeLa cells by a novel cationic porphycene photosensitizer. Ruiz-González R, Acedo P, Sánchez-García D, Nonell S, Cañete M, Stockert JC, Villanueva A. Eur J Med Chem; 2013 May 06; 63():401-14. PubMed ID: 23517729 [Abstract] [Full Text] [Related]
10. Photodynamic therapy with TMPyP - Porphyrine induces mitotic catastrophe and microtubule disorganization in HeLa and G361 cells, a comprehensive view of the action of the photosensitizer. Cenklová V. J Photochem Photobiol B; 2017 Aug 06; 173():522-537. PubMed ID: 28686960 [Abstract] [Full Text] [Related]
11. Iontophoresis Improved Growth Reduction of Invasive Squamous Cell Carcinoma in Topical Photodynamic Therapy. Lemos CN, de Souza JG, Simão PS, Lopez RF. PLoS One; 2016 Aug 06; 11(1):e0145922. PubMed ID: 26752697 [Abstract] [Full Text] [Related]
12. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine. Colombo LL, Vanzulli SI, Villanueva A, Cañete M, Juarranz A, Stockert JC. Int J Oncol; 2005 Oct 06; 27(4):1053-9. PubMed ID: 16142323 [Abstract] [Full Text] [Related]
13. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer. Kuzyniak W, Schmidt J, Glac W, Berkholz J, Steinemann G, Hoffmann B, Ermilov EA, Gürek AG, Ahsen V, Nitzsche B, Höpfner M. Int J Oncol; 2017 Mar 06; 50(3):953-963. PubMed ID: 28098886 [Abstract] [Full Text] [Related]
14. Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles. Yan S, Huang Q, Chen J, Song X, Chen Z, Huang M, Xu P, Zhang J. Int J Nanomedicine; 2019 Mar 06; 14():6799-6812. PubMed ID: 31692522 [Abstract] [Full Text] [Related]
15. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy. Gao D, Lo PC. J Control Release; 2018 Jul 28; 282():46-61. PubMed ID: 29673646 [Abstract] [Full Text] [Related]
17. Photodynamic performance of zinc phthalocyanine in HeLa cells: A comparison between DPCC liposomes and BSA as delivery systems. M Garcia A, de Alwis Weerasekera H, Pitre SP, McNeill B, Lissi E, Edwards AM, Alarcon EI. J Photochem Photobiol B; 2016 Oct 28; 163():385-90. PubMed ID: 27614847 [Abstract] [Full Text] [Related]
18. Cervical cancer cells (HeLa) response to photodynamic therapy using a zinc phthalocyanine photosensitizer. Hodgkinson N, Kruger CA, Mokwena M, Abrahamse H. J Photochem Photobiol B; 2017 Dec 28; 177():32-38. PubMed ID: 29045918 [Abstract] [Full Text] [Related]
19. C-MYC and C-FOS expression changes and cellular aspects of the photodynamic reaction with photosensitizers TMPyP and ClAlPcS2. Pizova K, Bajgar R, Fillerova R, Kriegova E, Cenklova V, Langova K, Konecny P, Kolarova H. J Photochem Photobiol B; 2015 Jan 28; 142():186-96. PubMed ID: 25545333 [Abstract] [Full Text] [Related]
20. The effect of two porphyrine photosensitizers TMPyP and ZnTPPS4 for application in photodynamic therapy of cancer cells in vitro. Žárská L, Malá Z, Langová K, Malina L, Binder S, Bajgar R, Kolářová H. Photodiagnosis Photodyn Ther; 2021 Jun 28; 34():102224. PubMed ID: 33609757 [Abstract] [Full Text] [Related] Page: [Next] [New Search]